Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps.

ABSTRACT: Political momentum and funding for combatting antimicrobial resistance (AMR) continues to build. Numerous major international and national initiatives aimed at financially incentivising the research and development (R&D) of antibiotics have been implemented. However, it remains unclear how to effectively strengthen the current set of incentive programmes to further accelerate antibiotic innovation. Based on a literature review and expert input, this study first identifies and assesses the major international, European Union, US and UK antibiotic R&D funding programmes. These programmes are then evaluated across market and public health criteria necessary for comprehensively improving the antibiotic market. The current set of incentive programmes are an important initial step to improving t

SUBMITTER: Simpkin VL 

PROVIDER: S-EPMC5746591 | biostudies-literature | 2017 Dec

REPOSITORIES: biostudies-literature